• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物利用研究作为卫生经济学中的工具。

Drug utilisation studies as tools in health economics.

作者信息

Sacristán J A, Soto J

机构信息

Health Economics Department, Lilly S.A., Madrid, Spain.

出版信息

Pharmacoeconomics. 1994 Apr;5(4):299-312. doi: 10.2165/00019053-199405040-00005.

DOI:10.2165/00019053-199405040-00005
PMID:10147239
Abstract

Drug utilisation and many pharmacoeconomic studies use pharmacoepidemiological methods characterised by the study of drugs from a socioeconomic perspective. Drug utilisation studies may be defined as studies of the marketing, distribution, prescription and use of drugs in a society, with special emphasis on the resulting medical, social and economic consequences. Pharmacoeconomic studies are used to measure drug efficiency, through comparison of the costs and effects of alternative therapies. Drug utilisation studies can provide highly valuable information, at a reasonable price, on the costs and effects (harmful and beneficial) of drugs. Such studies make available much useful information including indirect data on morbidity, the pharmaceutical component of the treatment cost of an illness, therapeutic compliance, the incidence of adverse reactions, the effectiveness of drug consumption and the choice of comparators. This information can be of great use in the subsequent elaboration of pharmacoeconomic studies, or in the selection of problematic areas in which these studies may be applied. Pharmacoeconomic studies, in turn, can be used to discover the economic repercussions of inappropriate prescribing and to quantify the cost effectiveness of various therapeutic interventions. The use of drug utilisation studies in conjunction with pharmacoeconomic analysis can result in more cost effective utilisation of medicines and a better utilisation of pharmacoeconomic methods, both of which contribute to a more rational use of drugs.

摘要

药物利用研究以及许多药物经济学研究采用了药物流行病学方法,其特点是从社会经济角度对药物进行研究。药物利用研究可定义为对一个社会中药物的营销、分销、处方和使用情况的研究,特别强调由此产生的医学、社会和经济后果。药物经济学研究用于通过比较替代疗法的成本和效果来衡量药物疗效。药物利用研究能够以合理的成本提供有关药物成本和效果(有害和有益)的极有价值的信息。此类研究可提供许多有用信息,包括发病率的间接数据、疾病治疗成本中的药物成分、治疗依从性、不良反应发生率、药物消费的有效性以及对照物的选择。这些信息在随后开展药物经济学研究或选择可应用这些研究的问题领域时可能非常有用。反过来,药物经济学研究可用于发现不适当处方的经济影响,并量化各种治疗干预措施的成本效益。将药物利用研究与药物经济学分析结合使用,可实现更具成本效益的药物利用,并更好地运用药物经济学方法,这两者都有助于更合理地使用药物。

相似文献

1
Drug utilisation studies as tools in health economics.药物利用研究作为卫生经济学中的工具。
Pharmacoeconomics. 1994 Apr;5(4):299-312. doi: 10.2165/00019053-199405040-00005.
2
Use of pharmacoeconomics in prescribing research. Part 1: costs--moving beyond the acquisition price for drugs.药物经济学在处方研究中的应用。第1部分:成本——超越药品采购价格
J Clin Pharm Ther. 2003 Feb;28(1):73-9. doi: 10.1046/j.1365-2710.2003.00452.x.
3
[Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].[药物经济学分析与奥地利药品定价及报销决策的相关性]
Wien Med Wochenschr. 2006 Dec;156(23-24):612-8. doi: 10.1007/s10354-006-0357-7.
4
The role of pharmacoeconomics in disease management. A pharmaceutical benefit management company perspective.药物经济学在疾病管理中的作用。从药品福利管理公司的角度来看。
Pharmacoeconomics. 1996;9 Suppl 1:9-15. doi: 10.2165/00019053-199600091-00004.
5
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.瑞格列奈:对其在2型糖尿病治疗中应用的药物经济学综述
Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005.
6
RATIONAL PHARMACOTHERAPY ON THE BASIS OF PHARMACOECONOMIC JUSTIFICATION AND MARKETING RESEARCH ON THE APPLICATION OF IMMUNOMODULATORY PHYTOPREPARATIONS.基于药物经济学论证的合理药物治疗与免疫调节剂植物制剂应用的市场研究。
Wiad Lek. 2023;76(4):824-830. doi: 10.36740/WLek202304119.
7
Institutional formularies: the relevance of pharmacoeconomic analysis to formulary decisions.机构处方集:药物经济学分析与处方集决策的相关性。
Pharmacoeconomics. 1992 Apr;1(4):265-81. doi: 10.2165/00019053-199201040-00004.
8
The rationale of pharmacoeconomic analysis in rheumatologic indications.药物经济学分析在风湿学适应证中的原理。
Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S64-71. Epub 2012 Oct 18.
9
Pharmacoeconomic consequences of measurement and modification of hospital drug use.医院用药计量与调整的药物经济学后果
Pharmacoeconomics. 1992 Jul;2(1):15-33. doi: 10.2165/00019053-199202010-00004.
10
[Cost-effectiveness of new drugs impacts reimbursement decision making but room for improvement].新药的成本效益影响报销决策,但仍有改进空间。
Ned Tijdschr Geneeskd. 2010;154:A958.

引用本文的文献

1
Effectiveness of disease-modifying agents in ameliorating multiple sclerosis - A cross-sectional observational study.疾病修饰药物改善多发性硬化症的有效性——一项横断面观察性研究。
Indian J Pharmacol. 2025 Mar 1;57(2):90-96. doi: 10.4103/ijp.ijp_493_23. Epub 2025 Jun 13.
2
Systematic review of survey/questionnaire-based drug utilization studies in Turkiye.土耳其基于调查/问卷的药物利用研究的系统评价。
North Clin Istanb. 2024 Nov 22;11(6):525-533. doi: 10.14744/nci.2024.60252. eCollection 2024.
3
Drug utilization studies in Turkiye: A systematic review.

本文引用的文献

1
Statistical aspects of the analysis of data from retrospective studies of disease.疾病回顾性研究数据的统计分析方面
J Natl Cancer Inst. 1959 Apr;22(4):719-48.
2
Reducing drug therapy-induced hospitalization: impact of drug utilization review.
Drug Inf J. 1982 Oct-Dec;16(4):199-202. doi: 10.1177/009286158201600409.
3
Medication, quality of life and compliance: the role of the pharmacist.
Pharmacoeconomics. 1992 Apr;1(4):225-30. doi: 10.2165/00019053-199201040-00001.
4
土耳其的药物利用研究:一项系统评价。
North Clin Istanb. 2024 Feb 1;11(1):10-17. doi: 10.14744/nci.2023.60134. eCollection 2024.
4
Drug utilization research in Peru: Is real-world data available?秘鲁的药物利用研究:是否有真实世界数据可用?
Front Pharmacol. 2023 Jan 17;13:1047946. doi: 10.3389/fphar.2022.1047946. eCollection 2022.
5
Dispensing of psychotropic drugs to adults in community pharmacies in Latvia.在拉脱维亚社区药房向成年人配发精神药物。
Pharm World Sci. 2008 Dec;30(6):934-9. doi: 10.1007/s11096-008-9256-x. Epub 2008 Oct 7.
6
Evaluation of human albumin use in a university hospital in Belgium.
Pharm World Sci. 2002 Jun;24(3):111-6. doi: 10.1023/a:1016120917510.
7
A survey of population-based drug databases in Canada.加拿大基于人群的药物数据库调查。
CMAJ. 1996 Jun 15;154(12):1855-64.
8
Antimicrobial drug utilisation in hospitals in Italy and other European countries.意大利及其他欧洲国家医院中抗菌药物的使用情况。
Infection. 1994;22 Suppl 3:S176-81. doi: 10.1007/BF01782703.
9
Drugs, money and society.毒品、金钱与社会。
Br J Clin Pharmacol. 1995 Apr;39(4):343-5. doi: 10.1111/j.1365-2125.1995.tb04461.x.
Economic analysis as an aid to subsidisation decisions: the development of Australian guidelines for pharmaceuticals.作为补贴决策辅助手段的经济分析:澳大利亚药品指南的制定
Pharmacoeconomics. 1992 Jan;1(1):54-67. doi: 10.2165/00019053-199201010-00010.
5
Principles of pharmacoeconomic analysis of drug therapy.药物治疗的药物经济学分析原则。
Pharmacoeconomics. 1992 Jan;1(1):20-31. doi: 10.2165/00019053-199201010-00006.
6
Impact of drug usage review on drug utilisation.药物使用审查对药物利用的影响。
Pharmacoeconomics. 1993 Jan;3(1):14-21. doi: 10.2165/00019053-199303010-00003.
7
Comparison of prescribing habits of general practitioners in The Netherlands versus England and Wales.
Pharmacoeconomics. 1992 Jul;2(1):77-86. doi: 10.2165/00019053-199202010-00009.
8
Pharmacoeconomic consequences of measurement and modification of hospital drug use.医院用药计量与调整的药物经济学后果
Pharmacoeconomics. 1992 Jul;2(1):15-33. doi: 10.2165/00019053-199202010-00004.
9
Cost-of-illness studies: a major headache?疾病成本研究:一大难题?
Pharmacoeconomics. 1992 Jul;2(1):1-4. doi: 10.2165/00019053-199202010-00001.
10
Health economics in primary care in the UK: containment of drug costs.英国初级医疗保健中的卫生经济学:控制药品成本
Pharmacoeconomics. 1993 Feb;3(2):100-6. doi: 10.2165/00019053-199303020-00003.